Page last updated: 2024-10-26

etidronate and Myocardial Ischemia

etidronate has been researched along with Myocardial Ischemia in 2 studies

Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.

Myocardial Ischemia: A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).

Research Excerpts

ExcerptRelevanceReference
"Comorbid factors such as ischemic heart disease, hip osteoarthritis, and higher values of FRAX blunted the effects of QOL of the treatment."1.38The effect of risedronate (17.5 mg/week) treatment on quality of life in Japanese women with osteoporosis: a prospective observational study. ( Hayakawa, Y; Iinuma, N; Itoh, M; Iwayama, S; Kamisaki, T; Nakamura, T; Nishikawa, M; Osawa, M; Suzuki, H; Yamaguchi, H, 2012)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nakamura, T1
Osawa, M1
Itoh, M1
Yamaguchi, H1
Iinuma, N1
Hayakawa, Y1
Suzuki, H1
Kamisaki, T1
Iwayama, S1
Nishikawa, M1
Ariyoshi, T1
Eishi, K1
Sakamoto, I1
Matsukuma, S1
Odate, T1

Trials

1 trial available for etidronate and Myocardial Ischemia

ArticleYear
Effect of etidronic acid on arterial calcification in dialysis patients.
    Clinical drug investigation, 2006, Volume: 26, Issue:4

    Topics: Aged; Aorta, Abdominal; Aorta, Thoracic; Bone Density Conservation Agents; Calcinosis; Coronary Vess

2006

Other Studies

1 other study available for etidronate and Myocardial Ischemia

ArticleYear
The effect of risedronate (17.5 mg/week) treatment on quality of life in Japanese women with osteoporosis: a prospective observational study.
    Journal of bone and mineral metabolism, 2012, Volume: 30, Issue:6

    Topics: Aged; Aged, 80 and over; Asian People; Bone Density; Bone Density Conservation Agents; Comorbidity;

2012